Use of dihydro myricotin element for treating cardiac blood diseases

The present invention discloses an application of dihydromyricetin in preparation of medicine for preventing or curing angiocardiopathy. The animal tests show that the dihydromyricetin has the effect for resisting internal phlebothrombosis, can be used for effectively preventing angiocardiopathy due...

Full description

Saved in:
Bibliographic Details
Main Author JIEPING QIN
Format Patent
LanguageEnglish
Published 29.08.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention discloses an application of dihydromyricetin in preparation of medicine for preventing or curing angiocardiopathy. The animal tests show that the dihydromyricetin has the effect for resisting internal phlebothrombosis, can be used for effectively preventing angiocardiopathy due to thrombosis, for example cardiac disease and apoplexy. Said invention can be made into medicine or health-care product.
Bibliography:Application Number: CN2007134610